Old dogs that learn new tricks: Modified antimicrobial agents that escape pre-existing resistance mechanisms

International Journal of Medical Microbiology

Volumn 296, Issue SUPPL. 2, 2006, Pages 45-49

  Schwarz, Stefan ^a   Kehrenberg, Corinna ^a  

^a INSTITUTE FOR EPIDEMIOLOGY AND PATHOGEN DIAGNOSTICS   (Germany)

Author keywords

New antibiotics; Resistance mechanisms; Target structures

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; PENICILLIN G; QUINOLONE DERIVATIVE; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CHEMICAL STRUCTURE; COST EFFECTIVENESS ANALYSIS; DOG; DRUG STRUCTURE; NONHUMAN; SHORT SURVEY;

EID: 33646853708     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2006.01.061     Document Type: Short Survey

References (23)

1. Ackermann G., and Rodloff A.C. Drugs of the 21st century: telithromycin (HMR3647) - the first ketolide. J. Antimicrob. Chemother. 51 (2003) 497-511
2. Bush K. Antibacterial drug discovery in the 21st century. Clin. Microbiol. Infect. 10 Suppl. 4 (2004) 10-17
3. Clarke T. Drug companies snub antibiotics as pipeline threatens to dry. Nature 442 (2003) 225
4. Davies J.E. Origins, acquisition and dissemination of antibiotic resistance determinants. In: Chadwick I., and Goode J. (Eds). Antibiotic Resistance: Origins, Evolution, Selection, and Spread. Ciba Foundation Symposium, vol. 207 (1997), Wiley, Chichester 15-27
5. Hansen L.H., Mauvais P., and Douthwaite S. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol. Microbiol. 31 (1999) 623-631
6. Holzgrabe U. Antibiotika-Entwicklung gestern und heute. Chemother. J. 13 (2004) 142-147
7. Kehrenberg C., Mumme J., Wallmann J., Verspohl J., Tegeler R., Kühn T., and Schwarz S. Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003. J. Antimicrob. Chemother. 54 (2004) 572-574
8. Liu M., and Douthwaite S. Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. Antimicrob. Agents Chemother. 46 (2002) 1629-1633
9. Livermore D.M. The need for new antibiotics. Clin. Microbiol. Infect. 10 Suppl. 4 (2004) 1-9
10. Mascaretti O. Bacteria Versus Antibacterial Agents: an Integrated Approach (2003), ASM Press, Washington, DC
11. Powers J.H. Antimicrobial drug development - the past, the present and the future. Clin. Microbiol. Infect. 10 Suppl. 4 (2004) 23-31
12. Priebe S., and Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob. Agents Chemother. 47 (2003) 2703-2705
13. Projan S.J., and Shlaes D.M. Antibacterial drug discovery: is it all downhill from here?. Clin. Microbiol. Infect. 10 Suppl. 4 (2004) 18-22
14. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Rood J.I., and Seppala H. Nomenclature for macrolide and macrolide-lincosamide streptogramin B antibiotic resistance determinants. Antimicrob. Agents Chemother. 43 (1999) 2823-2830
15. Schmitz F.J., Petridou J., Astfalk N., Scheuring S., Köhrer K., and Schwarz S. Molecular analysis of constitutively expressed erm(C) genes selected in-vitro by incubation in the presence of the non-inducers quinupristin, telithromycin or ABT-773. Microb. Drug Resist. 8 (2002) 171-177
16. Schmitz F.J., Petridou J., Jagusch H., Astfalk N., Scheuring S., and Schwarz S. Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin. J. Antimicrob. Chemother. 49 (2002) 611-617
17. Schmitz F.J., Petridou J., Milatovic D., Verhoef J., Fluit A.C., and Schwarz S. In vitro activity of new ketolides against macrolide-susceptible and macrolide-resistant Staphylococcus aureus isolates with defined resistance gene status. J. Antimicrob. Chemother. 49 (2002) 580-582
18. Schmitz F.J., Schwarz S., Milatovic D., Verhoef J., and Fluit A.C. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Moraxella catarrhalis. J. Antimicrob. Chemother. 50 (2002) 145-148
19. Schwarz S., and Chaslus-Dancla E. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet. Res. 32 (2001) 201-225
20. Schwarz S., Kehrenberg C., Doublet B., and Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 28 (2004) 519-542
21. Wallmann J., Schröter K., Wieler L.H., and Kroker R. Antibiotikaempfindlichkeit ausgewählter pathogener Bakterien von erkrankten Lebensmittel liefernden Tieren in Deutschland: Ergebnisse aus der Modellstudie 2001 des nationalen Resistenzmonitorings. Tierärztl. Praxis 31 G (2003) 122-131
22. Wallmann J., Kaspar H., and Kroker R. Prävalenzdaten zur Antibiotikaempfindlichkeit von bei Rindern und Schweinen isolierten bakteriellen Infektionserregern: Nationales BVL Resistenzmonitoring 2002/2003. Berl. Münch. Tierärztl. Wochenschr. 117 (2004) 480-492
23. Walsh C. Antibiotics: Actions, Origins, Resistance (2003), ASM Press, Washington, DC